These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15288907)

  • 21. Prostate-specific antigen kinetics in localized and advanced prostate cancer.
    Fitzpatrick JM; Banu E; Oudard S
    BJU Int; 2009 Mar; 103(5):578-87. PubMed ID: 19210674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate-specific antigen assay using whole blood samples spotted on filter paper and its application to mass screening for prostate cancer.
    Nanri M; Nanri K; Fujiyama C; Tokuda Y; Nakamura K; Uozumi J
    Int J Urol; 2007 Jun; 14(6):505-9. PubMed ID: 17593094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knowledge of oral cancer, distress and screening intentions: longer term effects of a patient information leaflet.
    Boundouki G; Humphris G; Field A
    Patient Educ Couns; 2004 Apr; 53(1):71-7. PubMed ID: 15062907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A community-based randomised controlled trial of three different educational resources for men about prostate cancer screening.
    Gattellari M; Ward JE
    Patient Educ Couns; 2005 May; 57(2):168-82. PubMed ID: 15911190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary heart disease knowledge test: developing a valid and reliable tool.
    Smith MM; Hicks VL; Heyward VH
    Nurse Pract; 1991 Apr; 16(4):28, 31, 35-8. PubMed ID: 2062470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knowledge levels of Korean intensive care nurses towards brain death and organ transplantation.
    Kim JR; Fisher M; Elliott D
    J Clin Nurs; 2006 May; 15(5):574-80. PubMed ID: 16629966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronary heart disease knowledge tool for women.
    Thanavaro JL; Thanavaro S; Delicath T
    J Am Acad Nurse Pract; 2010 Feb; 22(2):62-9. PubMed ID: 20132364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
    Schröder FH
    Can J Urol; 2005 Feb; 12 Suppl 1():2-6; discussion 92-3. PubMed ID: 15780157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacists as health educators and risk communicators in the early detection of prostate cancer.
    Odedina FT; Warrick C; Vilme H; Young S
    Res Social Adm Pharm; 2008 Mar; 4(1):59-66. PubMed ID: 18342823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of prostate cancer screening among health fair participants.
    Chiu BC; Anderson JR; Corbin D
    Public Health; 2005 Aug; 119(8):686-93. PubMed ID: 15949522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of PSA screening on the incidence of advanced stage prostate cancer in the United States: a surveillance modeling approach.
    Etzioni R; Gulati R; Falcon S; Penson DF
    Med Decis Making; 2008; 28(3):323-31. PubMed ID: 18319508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for prostate cancer in U.S. men ACPM position statement on preventive practice.
    Lim LS; Sherin K;
    Am J Prev Med; 2008 Feb; 34(2):164-70. PubMed ID: 18201648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years old.
    Loeb S; Roehl KA; Antenor JA; Catalona WJ; Suarez BK; Nadler RB
    Urology; 2006 Feb; 67(2):316-20. PubMed ID: 16442597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a reliable and valid nutritional knowledge questionnaire for urban South African adolescents.
    Whati LH; Senekal M; Steyn NP; Nel JH; Lombard C; Norris S
    Nutrition; 2005 Jan; 21(1):76-85. PubMed ID: 15661481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Practice patterns in screening and management of prostate cancer in elderly men.
    Konety BR; Sharp VJ; Verma M; Williams RD;
    Urology; 2006 Nov; 68(5):1051-6. PubMed ID: 17095076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PSA-based screening for prostate cancer: how does it compare with other cancer screening tests?
    Crawford ED; Abrahamsson PA
    Eur Urol; 2008 Aug; 54(2):262-73. PubMed ID: 18556114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Will men attribute fault to their GP for adverse effects arising from controversial screening tests? An Australian study using scenarios about PSA screening.
    Gattellari M; Ward JE
    J Med Screen; 2004; 11(4):165-9. PubMed ID: 15563771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for prostate cancer: updated experience from the Tyrol study.
    Horninger W; Berger A; Pelzer A; Klocker H; Oberaigner W; Schönitzer D; Severi G; Robertson C; Boyle P; Bartsch G
    Can J Urol; 2005 Feb; 12 Suppl 1():7-13; discussion 92-3. PubMed ID: 15780158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percent free PSA as an additional measure in a prostate cancer screen.
    Miele ME
    Clin Lab Sci; 2001; 14(2):102-7. PubMed ID: 15625982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Misclassifying the indications for prostate-specific antigen testing may bias case-control studies of the efficacy of prostate cancer screening.
    Hoffman RM; Adams-Cameron ML; Murata GH
    J Clin Epidemiol; 2004 Oct; 57(10):1071-5. PubMed ID: 15528058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.